Ijara Capital Partners has acquired Sindlab Pvt. Ltd., a diagnostic services chain operating over 30 outlets across Karachi, signaling a strategic push into the healthcare sector. The acquisition follows Ijara’s earlier investments in pharmaceutical and medical services, strengthening its integrated health portfolio.
Read More: Escorts Investment Bank Extends Offer Timeline for 6 % Stake Acquisition
“Sindlab’s extensive retail footprint and brand trust make it a strong strategic fit for Ijara’s expanding health portfolio,” said Farrukh Ansari, CEO of Ijara Capital. Sindlab is known for competitively priced clinical tests, radiology, and ultrasound services. The deal augments Ijara’s presence in healthcare, adding diagnostics to its existing interests.
The acquisition gives Ijara control over Sindlab’s operations, enabling synergies in procurement, scaling, and cross-service partnerships. The firm says it will invest in modernization, new equipment, and expanded outreach across underserved communities. Analysts expect this move to accelerate consolidation in Pakistan’s fragmented diagnostics sector.
With health being a vital growth and impact area in emerging markets, Ijara’s acquisition of Sindlab positions it not only as an investor but as a provider of medically necessary services, aligning investment returns with public benefit.
